Victor E Velculescu

49PUBLICATIONS
289CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 23, 2026
Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study.

|Apr 19, 2026
plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

|Mar 04, 2026
Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases.

Akshaya V Annapragada, Zachariah H Foda, Hope Orjuela

|Feb 06, 2026
Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial.

Blair V Landon, Julia L Boland, Andrea E Wahner Hendrickson

|Feb 06, 2026
Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection-Reply.

Peter J Mazzone, Peter B Bach, Robert B Scharpf

|Jan 27, 2026
Epigenetic Instability-Based Metrics in Cell-Free DNA for Early Cancer Detection.

Sara-Jayne Thursby, Zhicheng Jin, Jacob Blum

Pageof 9

Frequent Collaborators

20 joint publications

Valsamo Anagnostou

20 joint publications

Robert B Scharpf

15 joint publications

Jillian Phallen

13 joint publications

Jamie Medina